A first trimester prediction model for gestational diabetes utilizing aneuploidy and pre-eclampsia screening markers.
Arianne N SweetingJencia WongHeidi AppelblomGlynis P RossHeikki KouruPaul F WilliamsMikko SairanenJon A HyettPublished in: The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians (2017)
Addition of aneuploidy and pre-eclampsia markers is cost-effective and enhances early GDM detection, accurately identifying early GDM, a high-risk cohort requiring early detection, and intervention. Ethnicity and parity modified marker association with GDM, suggesting differences in pathophysiology and vascular risk.